These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 34785628)

  • 1. Why are some coronavirus variants more infectious?
    Mukherjee R; Satardekar R
    J Biosci; 2021; 46(4):. PubMed ID: 34785628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.
    Andreano E; Piccini G; Licastro D; Casalino L; Johnson NV; Paciello I; Dal Monego S; Pantano E; Manganaro N; Manenti A; Manna R; Casa E; Hyseni I; Benincasa L; Montomoli E; Amaro RE; McLellan JS; Rappuoli R
    Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34417349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of interactions between the D614G variant of SARS-CoV-2 S-protein and neutralizing antibodies: A computational approach.
    Kwarteng A; Asiedu E; Sylverken AA; Larbi A; Sakyi SA; Asiedu SO
    Infect Genet Evol; 2021 Jul; 91():104815. PubMed ID: 33774178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omicron: a drug developer's perspective.
    Fang FF; Shi PY
    Emerg Microbes Infect; 2022 Dec; 11(1):208-211. PubMed ID: 34951568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.
    Fuentes-Prior P
    J Biol Chem; 2021; 296():100135. PubMed ID: 33268377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the Double Mutants on Spike Protein of SARS-CoV-2 B.1.617 Lineage on the Human ACE2 Receptor Binding: A Structural Insight.
    Khan MI; Baig MH; Mondal T; Alorabi M; Sharma T; Dong JJ; Cho JY
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity.
    Huang SW; Wang SF
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging plasticity of SARS-CoV-2.
    McCormick KD; Jacobs JL; Mellors JW
    Science; 2021 Mar; 371(6536):1306-1308. PubMed ID: 33766871
    [No Abstract]   [Full Text] [Related]  

  • 9. Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment.
    Malladi SK; Singh R; Pandey S; Gayathri S; Kanjo K; Ahmed S; Khan MS; Kalita P; Girish N; Upadhyaya A; Reddy P; Pramanick I; Bhasin M; Mani S; Bhattacharyya S; Joseph J; Thankamani K; Raj VS; Dutta S; Singh R; Nadig G; Varadarajan R
    J Biol Chem; 2021; 296():100025. PubMed ID: 33154165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry.
    Azad T; Singaravelu R; Taha Z; Jamieson TR; Boulton S; Crupi MJF; Martin NT; Fekete EEF; Poutou J; Ghahremani M; Pelin A; Nouri K; Rezaei R; Marshall CB; Enomoto M; Arulanandam R; Alluqmani N; Samson R; Gingras AC; Cameron DW; Greer PA; Ilkow CS; Diallo JS; Bell JC
    Mol Ther; 2021 Jun; 29(6):1984-2000. PubMed ID: 33578036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of SARS-CoV-2 Omicron spike RBD reveals significantly decreased stability, severe evasion of neutralizing-antibody recognition but unaffected engagement by decoy ACE2 modified for enhanced RBD binding.
    Lin S; Chen Z; Zhang X; Wen A; Yuan X; Yu C; Yang J; He B; Cao Y; Lu G
    Signal Transduct Target Ther; 2022 Feb; 7(1):56. PubMed ID: 35190526
    [No Abstract]   [Full Text] [Related]  

  • 12. The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization.
    Bayarri-Olmos R; Rosbjerg A; Johnsen LB; Helgstrand C; Bak-Thomsen T; Garred P; Skjoedt MO
    J Biol Chem; 2021; 296():100536. PubMed ID: 33716040
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Kumar A; Panwar A; Batra K; De S; Maan S
    Comb Chem High Throughput Screen; 2021; 24(10):1769-1783. PubMed ID: 33172369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The great escape? SARS-CoV-2 variants evading neutralizing responses.
    Prévost J; Finzi A
    Cell Host Microbe; 2021 Mar; 29(3):322-324. PubMed ID: 33705702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 journey: from alpha variant to omicron and its sub-variants.
    Hattab D; Amer MFA; Al-Alami ZM; Bakhtiar A
    Infection; 2024 Jun; 52(3):767-786. PubMed ID: 38554253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion.
    Baral P; Bhattarai N; Hossen ML; Stebliankin V; Gerstman BS; Narasimhan G; Chapagain PP
    Biochem Biophys Res Commun; 2021 Oct; 574():14-19. PubMed ID: 34425281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants.
    Cai Y; Zhang J; Xiao T; Lavine CL; Rawson S; Peng H; Zhu H; Anand K; Tong P; Gautam A; Lu S; Sterling SM; Walsh RM; Rits-Volloch S; Lu J; Wesemann DR; Yang W; Seaman MS; Chen B
    Science; 2021 Aug; 373(6555):642-648. PubMed ID: 34168070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational Hotspot in the SARS-CoV-2 Spike Protein N-Terminal Domain Conferring Immune Escape Potential.
    Kubik S; Arrigo N; Bonet J; Xu Z
    Viruses; 2021 Oct; 13(11):. PubMed ID: 34834921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.
    Thomson EC; Rosen LE; Shepherd JG; Spreafico R; da Silva Filipe A; Wojcechowskyj JA; Davis C; Piccoli L; Pascall DJ; Dillen J; Lytras S; Czudnochowski N; Shah R; Meury M; Jesudason N; De Marco A; Li K; Bassi J; O'Toole A; Pinto D; Colquhoun RM; Culap K; Jackson B; Zatta F; Rambaut A; Jaconi S; Sreenu VB; Nix J; Zhang I; Jarrett RF; Glass WG; Beltramello M; Nomikou K; Pizzuto M; Tong L; Cameroni E; Croll TI; Johnson N; Di Iulio J; Wickenhagen A; Ceschi A; Harbison AM; Mair D; Ferrari P; Smollett K; Sallusto F; Carmichael S; Garzoni C; Nichols J; Galli M; Hughes J; Riva A; Ho A; Schiuma M; Semple MG; Openshaw PJM; Fadda E; Baillie JK; Chodera JD; ; ; Rihn SJ; Lycett SJ; Virgin HW; Telenti A; Corti D; Robertson DL; Snell G
    Cell; 2021 Mar; 184(5):1171-1187.e20. PubMed ID: 33621484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.